Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.72 |
| ▸ | PRKCA | P17252 | 3/20 | 0.67 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.67 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.67 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.67 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.60 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.60 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.53 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2899991 | 0.95 | FABP3 (0.65) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| Hydrochloric Acid SCHEMBL415484 | 0.93 | FABP3 (0.79) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| Diolein SCHEMBL16100175 | 0.92 | PRKCA (0.71) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL13695210 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL20494173 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL25403277 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL18025185 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL21713133 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL4991825 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL21641641 | 0.91 | FABP3 (0.88) | FABP3PRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10076567-B2 | MPER-liposome conjugates and uses thereof | DUKE UNIVERSITY (US) | 2018-09-18 | — | — | US | disclosed |
| US-20170014503-A1 | MPER-LIPOSOME CONJUGATES AND USES THEREOF | LOS ALAMOS NATIONAL SECURITY, LLC | 2017-01-19 | — | — | US | disclosed |
| US-9402917-B2 | Methods for the induction of broadly anti-HIV-1 neutralizing antibody responses employing liposome-MPER peptide compositions | DUKE UNIVERSITY (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150147387-A1 | METHOD OF INDUCING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS INVOLVING THE ADMINISTRATION OF MPER PEPTIDE-LIPOSOME CONJUGATES | DUKE UNIVERSITY | 2015-05-28 | — | — | US | disclosed |
| US-8956627-B2 | Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates | DUKE UNIVERSITY (US) | 2015-02-17 | — | — | US | disclosed |
| US-20140322262-A1 | METHOD OF INDUCING NEUTRALIZING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | DUKE UNIVERSITY (NC) | 2014-10-30 | — | — | US | disclosed |
| EP-2694533-A2 | METHOD OF INDUCING NEUTRALIZING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | Duke University (US) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012139097-A2 | METHOD OF INDUCING NEUTRALIZING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | DUKE UNIVERSITY (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120177721-A1 | FORMULATION | CHILDREN'S MEDICAL CENTER CORPORATION | 2012-07-12 | — | — | US | disclosed |
| US-20120128758-A1 | FORMULATION FOR INDUCING BROADLY REACTIVE NEUTRALIZING ANTI-HIV ANTIBODIES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-05-24 | — | — | US | disclosed |
| US-20120070488-A1 | METHOD OF INDUCING NEUTRALIZING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | DUKE UNIVERSITY (US) | 2012-03-22 | — | — | US | disclosed |
| US-20100047331-A1 | METHOD OF INDUCING NEUTRALIZING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-25 | — | — | US | disclosed |